Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Hepatocellular 37Liver Neoplasms 18Neoplasm Metastasis 17Colorectal Neoplasms 13Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 8Colonic Neoplasms 8Breast Neoplasms 8Barrett Esophagus 7Recurrence 6Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Thyroid Neoplasms 5Rectal Neoplasms 5Thyroid Nodule 4Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Biliary Tract Neoplasms 3Agnosia 3Thyroid Diseases 2Prostatic Neoplasms 2Leiomyoma 2Hyperaldosteronism 2Cancer Pain 2Bile Duct Neoplasms 2Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 326Carboplatin 318Bevacizumab 167Gemcitabine 106pembrolizumab 101liposomal doxorubicin 100Cyclophosphamide 96Topotecan 93Cisplatin 89olaparib 86niraparib 60Docetaxel 56Taxes 52Doxorubicin 50Drug Therapy 42fludarabine 40Filgrastim 39Nivolumab 37Etoposide 32Specimen Handling 31Magnetic Resonance Spectroscopy 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Albumin-Bound Paclitaxel 25durvalumab 24aldesleukin 24Hyperthermic Intraperitoneal Chemotherapy 24Oxaliplatin 23Biopsy 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ovarian Neoplasms × Radiofrequency Ablation × Clear all
NCT02487693 2016-02-23

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

The First People's Hospital of Changzhou

Phase 2 Active not recruiting
50 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡